Cost-effectiveness analysis of transcatheter aortic valve implantation in aortic stenosis patients at low- and intermediate-surgical risk in Japan

CONCLUSIONS: TAVI was dominant and cost-effective compared to SAVR in intermediate- and low-risk patients, respectively. These results suggest that TAVI can provide meaningful value to Japanese patients relative to SAVR, at a reasonable incremental cost for patients at low surgical risk and potentially resulting in cost-savings in patients at intermediate surgical risk.PMID:38654415 | DOI:10.1080/13696998.2024.2346397

Source: Journal of Medical Economics - April 24, 2024 Category: Health Management Authors: Junjiro Kobayashi Suzanne J Baron Kensuke Takagi Christin A Thompson Xiayu Jiao Kaoru Yamabe Source Type: research